Dr Fiona Murphy

Lecturer

Strathclyde Institute of Pharmacy and Biomedical Sciences

Contact

Personal statement

My research focuses on identifying the hazards to human health posed by inhalation exposure to aerosolised particles and nanomaterials. Recent focus is on the development of physiologically-relevant in vitro models to reduce the reliance on rodent models for hazard assessment of novel materials and to improve our understanding of the underlying mechanism of particle-related lung disease.

Back to staff profile

Publications

Non-cyclic nucleotide EPAC1 activators suppress lipopolysaccharide-regulated gene expression, signalling and intracellular communication in differentiated macrophage-like THP-1 cells
Wiejak Jolanta, Murphy Fiona A, Barker Graeme, Maffia Pasquale, Yarwood Stephen J
Cellular Signalling Vol 124 (2024)
https://doi.org/10.1016/j.cellsig.2024.111444
Differential roles for the oxygen sensing enzymes PHD1 and PHD3 in the regulation of neutrophil metabolism and function
Watts Emily, Willison Joseph, Arienti Simone, Sadiku Pranvera, Coelho Patricia, Sanchez-Garcia Manuel, Zhang Ailiang, Murphy Fiona, Dickinson Rebecca, Mirchandani Ananda, Morrison Tyler, Lewis Amy, Vermaelen Wesley, Ghesquiere Bart, Carmeliet Peter, Mazzone Massimilliano, Maxwell Patrick, Pugh Christopher, Dockrell David, Whyte Moira, Walmsley Sarah
Wellcome Open Research Vol 8 (2024)
https://doi.org/10.12688/wellcomeopenres.19915.2
Humanising nanotoxicology : moving towards animal-free approaches for hazard assessment of nanomaterials
Murphy Fiona
Society of Toxicology (2024)
Similarity of multicomponent nanomaterials in a safer-by-design context : the case of core–shell quantum dots
Di Battista Veronica, Sanchez-Lievanos Karla R, Jeliazkova Nina, Murphy Fiona, Tsiliki Georgia, Zabeo Alex, Gajewicz-Skretna Agnieszka, Mikołajczyk Alicja, Hristozov Danail, Stone Vicki, Schmid Otmar, Hunt Neil, Oomen Agnes G, Wohlleben Wendel
Environmental Science: Nano Vol 11, pp. 924-941 (2024)
https://doi.org/10.1039/D3EN00338H
Vascular smooth muscle cells enhance immune/vascular interplay in a 3-cell model of vascular inflammation
Wiejak Jolanta, Murphy Fiona A, Maffia Pasquale, Yarwood Stephen J
Scientific Reports Vol 13 (2023)
https://doi.org/10.1038/s41598-023-43221-8
How to formulate hypotheses and IATAs to support grouping and read-across of nanoforms
Murphy Fiona A, Johnston Helinor J, Dekkers Susan, Bleeker Eric AJ, Oomen Agnes G, Fernandes Teresa F, Rasmussen Kirsten, Jantunen Paula, Rauscher Hubert, Hunt Neil, di Cristo Luisana, Braakhuis Hedwig M, Haase Andrea, Hristozov Danail, Wohlleben Wendel, Sabella Stefania, Stone Vicki
Altex Vol 40, pp. 125-140 (2023)
https://doi.org/10.14573/altex.2203241

More publications

Back to staff profile

Professional Activities

SIPBS Open Doors Day
Chair
8/6/2024
NC3Rs NAMs-Net Launch
Participant
30/4/2024
MSci external examiner
Examiner
22/3/2024
Society of Toxicology
Speaker
2024
Animal Free Research UK Scientific Conference
Speaker
4/10/2023
NC3Rs Galleria mellonella worksop
Speaker
13/9/2023

More professional activities

Projects

Validation of Scinora serum-free media formulations and Xplace supplement for the development of animal-free NAMs for nanotoxicology
Murphy, Fiona (Principal Investigator)
01-Oct-2024 - 31-Mar-2025
DTP 2224 University of Strathclyde | McAllister, Katie
Perrie, Yvonne (Principal Investigator) Murphy, Fiona (Co-investigator) McAllister, Katie (Research Co-investigator)
01-Oct-2024 - 01-Apr-2028
Generation of physiologically-reelevant mesothelioma tumour spheroids using tunable hydrogel scaffolds for improved preclinical drug screening
Murphy, Fiona (Principal Investigator)
01-Aug-2024 - 31-Jul-2025
Developing the Chick Chorioallantoic Membrane (CAM) model for hazard assessment of High Aspect Ratio Nanomaterials
Murphy, Fiona (Principal Investigator)
07-Jan-2024 - 06-Jan-2025
Development of a physiologically-relevant in vitro model of the lung alveolar space, incorporating novel peptide hydrogels as biomimetic extracellular matrix scaffolds
Murphy, Fiona (Principal Investigator)
01-May-2023 - 30-Apr-2024
Development of a physiologically-relevant in vitro model of the lung alveolar space, incorporating novel peptide hydrogels as biomimetic extracellular matrix scaffolds
Murphy, Fiona (Principal Investigator)
01-Sep-2022 - 31-Jul-2024

More projects

Back to staff profile

Contact

Dr Fiona Murphy
Lecturer
Strathclyde Institute of Pharmacy and Biomedical Sciences

Email: f.murphy@strath.ac.uk
Tel: Unlisted